New Delhi, India

Pawan Malhotra

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Council of Scientific and Industrial Research, International Centre for Genetic Engineering and Biotechnology (Icgeb). Active years: 2022.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pawan Malhotra: Innovator in Antimalarial Compounds

Introduction

Pawan Malhotra is a distinguished inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimalarial compounds. His innovative work aims to combat drug-resistant malaria, a pressing global health issue.

Latest Patents

Pawan Malhotra holds a patent for "Antimalarial compounds, process for preparation and their use for drug resistant malaria." This invention provides a new artemisinin-dipeptidyl vinyl based compound of Formula (I) or a pharmaceutically acceptable salt thereof, along with a process for its preparation. The patent also includes a pharmaceutical composition comprising compounds of Formula (I) or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent, or excipient to treat malaria. He has 1 patent to his name.

Career Highlights

Throughout his career, Pawan Malhotra has worked with notable organizations such as the Council of Scientific and Industrial Research and the International Centre for Genetic Engineering and Biotechnology. His work in these institutions has allowed him to contribute to significant advancements in biotechnology and pharmaceuticals.

Collaborations

Pawan has collaborated with esteemed colleagues, including Asish Kumar Bhattacharya and Eswar Kumar Aratikatla. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.

Conclusion

Pawan Malhotra's contributions to the development of antimalarial compounds highlight his commitment to addressing critical health challenges. His innovative work continues to pave the way for advancements in the treatment of malaria.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…